| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.200 | 10.316 | 5.518 | 5.863 | 5.748 | 2.062 | 2.752 | 14.131 | 6.942 | 7.586 |
| Total Income - EUR | 31.204 | 10.322 | 5.523 | 5.867 | 5.752 | 2.067 | 2.758 | 14.136 | 6.946 | 7.592 |
| Total Expenses - EUR | 21.961 | 9.656 | 3.803 | 4.752 | 4.180 | 1.768 | 2.274 | 12.388 | 6.298 | 9.339 |
| Gross Profit/Loss - EUR | 9.243 | 666 | 1.720 | 1.116 | 1.572 | 298 | 484 | 1.749 | 648 | -1.748 |
| Net Profit/Loss - EUR | 8.307 | 375 | 1.554 | 940 | 1.399 | 236 | 401 | 1.384 | 545 | -1.748 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Royal Duo M.d. 2005 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 218 | 595 | 250 | 26 | 0 | 0 | 0 | 501 | 387 | 96 |
| Current Assets | 23.295 | 15.878 | 17.393 | 18.095 | 19.071 | 13.751 | 13.846 | 9.218 | 9.778 | 8.493 |
| Inventories | 0 | 0 | 0 | 1.406 | 1.136 | 1.660 | 1.765 | 927 | 335 | 615 |
| Receivables | 0 | 0 | 213 | 0 | 0 | 0 | -417 | 0 | 1.186 | 1.395 |
| Cash | 23.295 | 15.878 | 17.180 | 16.689 | 17.935 | 12.092 | 12.498 | 8.291 | 8.257 | 6.483 |
| Shareholders Funds | 15.847 | 16.060 | 17.343 | 17.964 | 19.015 | 13.723 | 13.820 | 9.650 | 10.165 | 8.361 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.666 | 412 | 300 | 157 | 55 | 29 | 26 | 70 | 0 | 228 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Royal Duo M.d. 2005 S.r.l.